Frontlight ResearchEarly access
TerminatedNo phase
Strategy of Crossing Two Ablation Techniques (Cryoballoon and Radiofrequency) After the Recurrence of Paroxysmal AF and the Need for a New Procedure
Key facts
- Who runs it
- Galaxia Empírica
- Where
- Spain9 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 16 people enrolled
- Started
- 31 Aug 2021
- Ended
- 1 Feb 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Ablation
- Record updated
- 12 March 2024
- Why it stopped
- Low recruitment
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Paroxysmal FA (one that ends, spontaneously or not, within 7 days of its onset. GUIDELINES ESC FA 2020)
- Have undergone an initial AF ablation procedure using Cryoballoon or point-to-point focal RF within the three years prior to the initial visit
- During the initial AF ablation procedure ONLY pulmonary vein isolation / ablation will have been performed
- Documented recurrence of AF lasting more than 30 seconds after the first ablation procedure
- With the ability and willingness to sign the informed consent of the patient
- With a minimum follow-up capacity of 12 months
Who cannot take part
- Previous heart surgery
- Moderate or severe mitral valve disease
- Patients aged <18 years
- Severe dilation of the left atrium, defined as a volume greater than 48 ml / m2 or a left atrial diameter greater than 50 mm in the parasternal long axis
- Contraindication for anticoagulation
- Pregnancy or pregnancy intention during the 12-month follow-up
- Life expectancy less than 12 months
- Unavailability for follow-up for 12 months
- Simultaneous participation in another clinical trial
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Randomized phase III clinical trial to compare the efficacy of the two most widely used ablation techniques (cryotherapy and radiofrequency) after recurrence of atrial fibrillation (AF) in patients requiring a new ablation procedure.
The 2 groups in the trial
- Cross-over of ablation techniqueTreatment being tested
Cross-over of cardiac ablation procedures (cryotherapy and radiofrequency; radiofrequency and cryotherapy)
Treatment: Ablation
- Repetition of the same techniqueNo study treatment, for comparison
Repeat the same procedure (cryotherapy and cryotherapy; radiofrequency and radiofrequency)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- X-TRA CLINICAL TRIAL (X-therapy for Redo AF Ablation). Strategy of Crossing Two Ablation Techniques (Cryoballoon and Radiofrequency) After the Recurrence of Paroxysmal AF and the Need for a New Procedure
- Record updated
- 12 March 2024